Search Results (429)

Heart failure (HF) and myocardial infarction (MI) are interconnected syndromes with overlapping pathogenic pathways, including ischemia, neurohormonal activation, and maladaptive remodeling. Hypoxia-response genes, lipid-handling genes, and extracellular matrix (ECM) genes each influence these processes. Understanding their integrated roles can uncover biomarkers and targets. A systematic literature search was conducted (PubMed, Web of Science, and Scopus; 2000–2026; English-only, following PRISMA guidelines) to identify studies on key genes in hypoxia signaling, lipid metabolism, and ECM remodeling in MI/HF. Acute hypoxia (via HIFs) orchestrates metabolic adaptation and inflammation, but chronic HIF activation drives fibrosis and dysfunction. In parallel, genes controlling triglyceride and cholesterol handling (e.g., LPL, APOC3) influence energy supply and vascular risk. Variants in these genes modulate plasma lipids and MI/HF risk. For example, genetic loss-of-function in APOC3 lowers triglycerides and reduces coronary risk. ECM-related genes (e.g., COL4A1, LRP1) govern fibrosis and vascular integrity. Mutations in COL4A1 cause cardiomyocyte hypertrophy and severe fibrosis, while LRP1 regulates matrix remodeling and is upregulated in ischemic myocardium. Throughout, gene functions span acute repair versus chronic maladaptation. Findings derive from mixed sources: rodent models and cell studies demonstrate mechanistic links, while human genetics and cohorts link gene variants to HF/MI outcomes. Many promising biomarkers (e.g., circulating ITGA1) are preliminary, lacking large prospective validation. Not all cited therapeutic ideas have been tested in the treatment of human cardiac disease. The literature mix of species, models, and patient cohorts introduces heterogeneity. Full article

Our previous studies found that lipid emulsifiers can promote the absorption and deposition of liposoluble pigments in shrimp. The present study aimed to further investigate the effects of liposoluble pigments lutein (LUT) and lycopene (LYC), and their combination with lysophospholipids (LPL), on the growth performance, body coloration, and lipid composition of Pacific white shrimp Penaeusvannamei. Five diets were formulated: a control diet (Control), Control + 0.02% lutein (LUT), Control + 0.02% lycopene (LYC), LUT + 0.1% LPL (LUT + LPL), and LYC + 0.1% LPL (LYC + LPL). The feeding trial lasted for 8 weeks. There were no significant differences in shrimp growth and body composition among all groups. Both LUT and LYC increased the redness (a*) and yellowness (b*) of cooked shrimp. LPL synergistically enhanced the pigmentation-improving effects of LUT but weakened those of LYC. Additionally, LYC decreased the redness and yellowness of raw shrimp. Both LUT and LYC reduced the contents of saturated fatty acids and EPA while increasing the DHA content; LPL further enhanced this modulatory effect. In conclusion, LPL acts synergistically with LUT to improve the body coloration and modify the fatty acid composition of Pacific white shrimp, but its effect with LYC is limited. Full article

In prestack seismic inversion for structurally complex areas, elastic parameters commonly show strong directional heterogeneity (layer-parallel continuity versus cross-layer discontinuities), so conventional structure-guided schemes based on isotropic regularization often struggle to achieve both numerical stability and sharp interface resolution. To address this issue, we develop a structure-oriented, direction-decomposed Lp-L2 regularization method for prestack multi-trace joint inversion of P-wave velocity (Vp), S-wave velocity (Vs), and density (ρ). Dip information extracted from poststack seismic data is used to construct a dip-guided directional operator that locally projects the Cartesian model-gradient field onto the tangential and normal directions of the structural field, corresponding to along-layer and cross-layer components, respectively. Different priors are then imposed: L2 smoothing along layers enhances lateral continuity and stabilizes the inversion, whereas a nonconvex Lp sparsity constraint across layers concentrates updates at a limited number of geological discontinuities and preserves sharp contrasts at faults and bed boundaries, thereby mitigating the over-smoothing typical of dip-guided L2 inversion. The resulting formulation is embedded in a linearized prestack Amplitude Versus Offset (AVO) framework and solved efficiently using the Alternating Direction Method of Multipliers (ADMM) algorithm. Synthetic tests and field-data applications demonstrate improved delineation of faults and thin-bed boundaries under noise, with reduced errors and higher correlation relative to a classical structure-guided L2 approach. These results indicate that the proposed method provides a practical and effective route for high-resolution prestack elastic-parameter characterization in complex tectonic settings. Full article

This work presents a novel high-speed random bit generation approach based on chaotic optical signals combined with a pseudo-random pulse amplitude modulation (PAM) sequence. Chaotic dynamics generated by a laser diode under optical feedback provide the physical entropy source. At the same time, the PAM signal is added as an amplitude-level transformation to enhance the statistical distribution of the digitized signal. Unlike conventional post-processing techniques such as least significant bit (LSB) extraction, which reduce the effective bit rate, the proposed method described in this article preserves the full 8-bit resolution of the analog-to-digital converter improving the distribution of amplitude levels. Experimental results show a significant improvement in compliance with the NIST SP 800-22 statistical test suite. The system operates at a sampling rate of 20 GSa/s, achieving a theoretical bit generation rate of 160 Gb/s. These results demonstrate that the proposed approach provides an alternative to conventional digital post-processing techniques while maintaining high throughput. Full article

Synucleinopathies, including Parkinson’s disease and dementia with Lewy bodies, are characterized by progressive α-synuclein (α-Syn) aggregation accompanied by chronic neuroinflammatory changes. However, the mechanistic relationship between disrupted proteostasis and inflammatory signaling remains incompletely defined and may vary across disease stages and clinical subtypes. Lysophospholipids (LPLs) are bioactive lipids derived from membrane phospholipids that participate in diverse cellular processes. These functions are primarily mediated through G protein-coupled receptor (GPCR) signaling, but may also involve direct effects on membrane organization and biophysical properties. In addition to receptor-mediated pathways, the surrounding lipid environment may influence protein behavior, although its role in neurodegenerative processes remains to be fully elucidated. Within this framework, LPLs can be considered not only as signaling molecules but also as modulators of the cellular environment in which proteostasis and inflammatory responses occur. In this review, we adopt a lipid-centered perspective in which LPLs occupy an interface between lipid signaling, protein aggregation, and neuroinflammation. Rather than acting as a single initiating factor, altered lipid metabolism is likely to contribute through multiple interconnected pathways. Although current evidence is largely derived from preclinical studies, it supports a role for lipid-related mechanisms, particularly in early stages of synucleinopathy. Full article

Background/Objectives: Pigmented rice is increasingly recognized as a functional food because of its rich phytochemical composition and health-promoting potential. However, local red rice cultivars from the three southern border provinces of Thailand remain insufficiently characterized. This study comparatively evaluated four whole-grain red rice cultivars—Hawm Gra Dang Ngah 59 (HGDN 59), Hawm Mue Lau (HML), Lued Pla Lai (LPL), and Se Bu Kan Tang (SBKT)—for their chemical composition, antioxidant activities, and antidiabetic potential. Methods: Whole-grain rice samples were extracted with 95% ethanol and assessed for extraction yield, total phenolic content, and total flavonoid content. Antioxidant activity was measured using DPPH^•, FRAP, and anti-lipid peroxidation assays, while antidiabetic activity was measured using α-amylase and α-glucosidase inhibition assays. LC-MS/MS-based chemical profiling, pathway classification, PCA-based chemical space analysis, molecular docking against α-glucosidase, and physicochemical/ADMET prediction were also performed. Results: Among the tested cultivars, HGDN 59 showed the most favorable overall profile, with the highest phenolic content, strongest antioxidant activity, and marked α-glucosidase inhibitory activity. LC-MS/MS analysis combined with docking-based screening revealed that HGDN 59 contained several abundant compounds, including ent-Epicatechin-(4α→6)-ent-epicatechin, cinnamtannin A1, apiin, and α-tocotrienol. These compounds exhibited strong binding affinities toward α-glucosidase (−10.7 to −9.6 kcal/mol), comparable to or slightly more favorable than acarbose. ADMET prediction indicated that most polyphenolic compounds exceeded Lipinski’s rule of five, while α-tocotrienol demonstrated favorable absorption property. Conclusions: This is the first study to suggest that HGDN 59 exhibits potential α-glucosidase inhibitory activity in vitro and may serve as a promising functional food candidate for the dietary management of postprandial glycemic response. Full article

Adipogenesis is a critical factor in causing obesity, which is a global health problem associated with metabolic disorders, such as insulin resistance and cardiovascular diseases. Natural compounds with anti-adipogenic activity may represent potential approaches for modulating adipocyte function. However, despite increasing interest in natural products, the anti-adipogenic potential of acridone alkaloids, particularly prenylated derivatives, remains largely unexplored. This study examined the effects of N-methylatalaphylline (NMA), a prenylated acridone alkaloid, on adipocyte differentiation, lipid accumulation, and glucose uptake. NMA exhibited anti-adipogenesis, particularly toward preadipocytes, and significantly reduced lipid accumulation in murine 3T3-L1 and human PCS-210-010 adipocytes at nontoxic doses (1.5–6 µM). At 3–6 µM, NMA downregulated adipogenic regulators, including PPARγ, C/EBPα, and SREBP1, along with adipogenic effectors, such as FABP4, adiponectin, LPL, PLIN1, and FAS. Mechanistic studies indicated that NMA treatment was associated with reduced phosphorylation of AKT, ERK, and p38, accompanied by cell cycle arrest and inhibition of mitotic clonal expansion. Meanwhile, activation of AMPK-ACC signaling, which may contribute to suppression of adipogenesis and reduced glucose uptake, was observed in differentiated 3T3-L1 cells after treatment with 6 µM NMA for 48 h. Additionally, molecular docking and molecular dynamics simulations suggested potential interaction between NMA and ERK1, supported by hydrogen bonding and hydrophobic contacts. Overall, these findings suggest that NMA exerts anti-adipogenic effects in vitro by modulating adipocyte proliferation, differentiation, and lipid metabolism. These findings highlight NMA as a promising acridone alkaloid scaffold for anti-adiposity applications, warranting further in vivo validation. Full article

A 56-day feeding trial was conducted to evaluate the effects of varying dietary lipid and starch levels on growth performance, biochemical components, and hepatic glycolipid metabolism in hybrid grouper. Nine isonitrogenous diets were formulated to contain three levels of lipid (6%, 10%, or 14%) and starch (14%, 21%, or 28%) using a 3 × 3 factorial design. Juvenile fish (initial body weight: 19.06 ± 0.03 g) were randomly allocated to 27 floating net cages (25 fish per cage, three replicates per diet) in an indoor seawater recirculation system and hand-fed to apparent satiation twice daily. Two-way ANOVA was conducted to check treatment effects of dietary lipid and starch levels. No interaction effect between lipid and starch on growth and feed utilization was observed across all treatments; however, significant interactions between the two were observed for condition factor (CF), and some serum biochemical indicators and some hepatic glycolipid metabolic enzyme activities. Growth rate, specific growth rate, and feed efficiency (FE) exhibited a declining trend with increasing dietary lipid levels (p < 0.05). Conversely, hepatosomatic index (HSI), viscerosomatic index (VSI), condition factor, hepatic lipid and glycogen contents, muscle lipid content, serum triglyceride and high-density lipoprotein cholesterol contents, as well as hepatic carnitine palmitoyltransferase 1 (CPT-1) and lipoprotein lipase (LPL) activities, showed an increasing trend (p < 0.05). As lipid levels increased, serum total cholesterol (TC) and total protein (TP) contents dropped to a minimum at the intermediate lipid level (10%) and then rose, regardless of starch level. Hepatic fructose-1,6-bisphosphatase (FBP) activity increased significantly when lipid level rose from 6% to 10% (p < 0.05). With increasing dietary starch levels, HSI, VSI, hepatic and muscle glycogen contents, and serum low-density lipoprotein cholesterol content increased, while FE and serum TP content decreased (p < 0.05). Hepatic CPT-1, LPL, FBP, and pyruvate kinase activities were significantly enhanced when starch levels increased from 14% to 21% or 28% (p < 0.05). Serum aspartate aminotransferase activity was significantly higher in fish fed 14% lipid compared to those fed 6% or 10% lipid. These findings indicate that there is no interaction of dietary lipid and starch on growth and feed utilization, but high dietary lipid (14%) may enhance hepatic lipid oxidation while suppressing glycolysis, thereby limiting growth and promoting hepatic lipid deposition. The results provide a practical reference for optimizing dietary lipid and starch levels in cost-effective feed formulations for hybrid grouper. Full article

Lipolysis is an interfacial reaction. Lecithins are natural emulsifiers containing a mixture of phospholipids (PL). Lecithin composition can be modified via enzymatic hydrolysis of PLs to produce lysophospholipids (LPL). The quantities of PL and LPL and the PL/LPL ratio are related to the emulsifying properties and interfacial activity of digestive lipases. This study aims to: (i) produce oil-in-water nanoemulsions of rapeseed oil (RSO) with soybean lecithin (SBL) and hydrolyzed lecithin (HL) at different concentrations and homogenization pressures and measure the mean droplet diameter (MDD) and polydispersity index (PdI) by dynamic light scattering; (ii) hydrolyze the emulsions in vitro with intestinal extracts of rainbow trout and estimate the degree of hydrolysis of lipids (DH) by the pH-stat method; and (iii) model the results on MDD, PdI, and DH through the response surface methodology (RSM). When HL was used as an emulsifier, DH, MDD, and PdI were fitted to polynomial quadratic, two-factor interaction, and linear models, respectively. MDD, PdI, and DH were fitted to polynomial quadratic SBL models. The optimal conditions were emulsifier concentrations of 0.45% and 0.76% w/w and homogenization pressures of 10,790 and 10,781 psi for HL and SBL, respectively. Under these conditions, DH = 34.9% and 33.08%, MDD = 241.9 and 543.6 nm, and PdI = 0.29 and 0.52 for HL and SBL, respectively. Full article

This study compared the effects of dietary Lactobacillus plantarum (Lpl) and selenium-enriched L. plantarum (Lpl_se) on the growth, hepatic antioxidant capacity, and intestinal microbiota of juvenile largemouth bass (initial weight 12.50 ± 0.81 g). Following a 58-day trial in an indoor rearing system, data were analyzed using one-way ANOVA followed by Tukey’s HSD test. Results showed that both Lpl and Lpl_se significantly improved growth versus the control (Weight Gain Rate: 379.82% and 387.18% vs. 326.56%; p < 0.05). Both supplements significantly elevated hepatic antioxidant enzymes (SOD, CAT, GSH) and reduced malondialdehyde (MDA) levels (p < 0.05). Notably, these macroscopic parameters showed no statistical differences between the two probiotic treatments. However, 16S rRNA sequencing revealed distinct metabolic strategies. While both treatments enriched intestinal Lactobacillus, Lpl_se uniquely upregulated energy-harvesting and synthetic pathways (glycolysis and lysine biosynthesis), corroborated by increased intestinal glycogen synthase activity. In conclusion, while selenium enrichment did not further improve macroscopic growth statistically, it differentially modulated the intestinal functional profile towards enhanced carbohydrate and amino acid metabolism, presenting an alternative host nutrient assimilation strategy. Full article

Hypertriglyceridemia is a well-recognized contributor to residual atherosclerotic cardiovascular disease risk and a predisposing factor for acute pancreatitis. Despite the availability of pharmacologic agents and lifestyle interventions, patients with severe and refractory hypertriglyceridemia often fail to achieve adequate control. Recent advances in the molecular understanding of triglyceride metabolism have driven the development of targeted therapies that selectively modulate key regulatory pathways. This study sought to provide an overview of triglyceride regulation, the atherogenic role of remnant lipoproteins, and clinical evidence of emerging triglyceride-lowering therapies. Lipoprotein metabolism is regulated by a complex network of regulatory proteins that include lipoprotein lipase (LPL), apolipoproteins such as apolipoprotein C-III (ApoC-III), and angiopoietin-like proteins (ANGPTLs). Targeting these proteins in the metabolic cascade has shown promising results in reducing triglyceride levels. Emerging therapies such as antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) directed against ApoC-III (volanesorsen, olezarsen, and plozasiran), inhibitors of ANGPTL3 (evinacumab and zodasiran), and fibroblast growth factor 21 (FGF-21) analogs (pegozafermin) have demonstrated substantial triglyceride-lowering efficacy. These agents have achieved reductions in triglyceride levels of up to 80% in clinical trials. Additionally, preliminary evidence suggests that these agents may also reduce the incidence of acute pancreatitis and improve cardiometabolic risk profiles, although dedicated trials are still needed to confirm these outcomes. The therapeutic landscape for hypertriglyceridemia is rapidly evolving. Integrating these novel agents into clinical practice will require individualized treatment plans, sustained lifestyle modification, and careful safety monitoring. Full article

This study aimed to investigate the ameliorative effects of glucuronolactone (GL) as a dietary additive on high-fat diet (HFD)-induced growth suppression and metabolic disorders in turbot. A 10-week feeding trial was conducted using juvenile turbot (16.7 ± 0.03 g). Two diets with different protein (%)/lipid (%) levels were formulated: PC (54/12) and NC (47/17). Based on the NC diet, three experimental diets were prepared by supplementing 200 (G200), 400 (G400), and 600 (G600) mg/kg of GL. The present results show that compared to the PC group, HFDs significantly inhibited the growth performance of turbot and induced severe metabolic disorders, hepatointestinal damage, and gut microbiota dysbiosis. Dietary GL supplementation effectively reversed these adverse effects. Specifically, compared to the NC group, GL supplementation significantly restored growth performance, enhanced non-specific immunity, and systematically improved metabolic health. In the liver, GL notably ameliorated tissue damage and downregulated key lipogenic genes (SREBP1, ACC, FAS, PPARγ), while upregulating genes involved in lipid oxidation and catabolism (PPARα1, CPT1, ACOX1, HSL, LPL) and lipid transport (ApoB100, MTP), thereby alleviating hepatic lipid deposition. Furthermore, GL activated the Nrf2/Keap1 antioxidant pathway, up-regulating the expression of genes such as SOD, CAT, GPX, and HO-1. It also suppressed the NF-κB-mediated inflammatory response (downregulation of IL-1β, IFN-γ and TNF-α2; upregulation of IL-10 and TGF-β2) and the mitochondrial apoptosis pathway (increased Bcl-2/Bax ratio; downregulation of Caspase3/7/9), collectively mitigating oxidative damage and cellular apoptosis. Moreover, GL restored intestinal morphology, enhanced the expression of tight junction proteins (Claudin-3, Claudin-7, ZO-1, Occludin) and MUC2, and inhibited MLCK signaling. These improvements led to a reduction in serum D-LA levels, indicating strengthened intestinal barrier function. Concurrently, GL reshaped the gut microbiota composition by enriching beneficial bacteria such as Akkermansia and suppressing potential pathogens like Listeria. In summary, GL effectively alleviated HFD-induced growth suppression and metabolic damage in turbot by improving lipid metabolism and alleviating hepatic injury, while concurrently restoring intestinal barrier integrity and microbiota homeostasis. Full article

This experiment investigated the effects of dietary Artemisia ordosica Krasch. (AOK) supplementation on the n3-polyunsaturated fatty acid (n3-PUFA) profile of subcutaneous adipose tissue (SADT) in Arbas cashmere goats and explored the underlying transcriptional mechanisms. Forty healthy, weaned kids (120 ± 10 days of age; similar body weight) were randomly allocated to two groups (n = 20): a control group (CON, basal diet) and an AOK group (AOK, basal diet with 3% of the roughage replaced by AOK). The feeding trial spanned 104 days, consisting of a 14-day adaptation period and 90 days of data acquisition. Compared with the CON group, AOK significantly reduced the content of saturated fatty acids (SFAs) and n6-polyunsaturated fatty acids (n6-PUFAs)/n3-PUFAs (n6/n3). In contrast, the levels of n3-PUFAs in the SADT of cashmere goats increased markedly (p < 0.05). Compared with the CON group, AOK exhibited significantly higher activities of hormone-sensitive lipase (HSL) (p = 0.027), adenylyl cyclase 2 (ADCY2) (p = 0.010), adenylyl cyclase 5 (ADCY5) (p = 0.046), cluster of differentiation 36 (CD36) (p = 0.013), solute carrier family 27 member 4 (SLC27A4) (p = 0.021), and fatty acid binding protein 4 (FABP4) (p = 0.040), along with significantly lower activities of fatty acid synthase (FAS) (p = 0.002), lipoprotein lipase (LPL) (p = 0.048), and stearoyl-coa desaturase (SCD) (p = 0.026) in SADT. Compared with the CON group, the activities of superoxide dismutase (SOD) (p = 0.032), catalase (CAT) (p = 0.010), glutathione peroxidase (GSH-PX) (p = 0.029), and total antioxidant capacity (T-AOC) (p = 0.002) were significantly increased in the AOK group. Transcriptomic profiling revealed that AOK supplementation downregulated mRNA levels of ADCY2, ADCY5, LPL, FAS, SCD, stearoyl-CoA desaturase 1 (SCD1), stearoyl-CoA desaturase 2 (SCD2), glycogen synthase 1 (GYS1), acyl-CoA oxidase 1 (ACOX1), acetyl-CoA carboxylase (ACC), diacylglycerol acyltransferase 1 (DGAT1), fatty acid desaturase 1 (FADS1), solute carrier family 27 member 2 (SLC27A2), erythroblastic leukemia viral oncogene homolog 4 (ERBB4), and carnitine palmitoyltransferase 1B (CPT1B) (p < 0.05). It also markedly induced acyl-CoA synthetase long-chain family member 4 (ACSL4) (p < 0.01) in SADT. Genes significantly enriched in the adenosine-monophosphate-activated protein kinase (AMPK) signaling pathway included LPL, SCD1, CPT1B, and GYS1 (p = 0.010). Genes significantly enriched in the phosphatidylinositol 3-kinase-akt (PI3K-Akt) signaling pathway included GYS1 and ERBB4 (p = 0.015). CPT1B, ADCY2, and GYS1 were identified as the genes significantly enriched in the insulin resistance signaling pathway (p = 0.048). LPL was the only gene significantly enriched in the cholesterol metabolism pathway (p = 0.049). Genes showing a tendency toward significant enrichment in the peroxisome-proliferator-activated receptor (PPAR) signaling pathway included ACSL4, CPT1B, SCD1, and LPL (p = 0.051). These interconnected cascades improve insulin sensitivity, stimulate triglyceride (TG) hydrolysis, and modulate n3-PUFA levels. Supplementation with AOK enhances n3-PUFA content by accelerating TG breakdown while simultaneously restraining FA oxidation in SADT. Consequently, AOK supplementation can be effectively used to enhance the nutritional value of cashmere goat meat through improved n3-PUFA deposition in SADT. Full article

Background: Subcutaneous fat deposition critically impacts duck meat quality and feed efficiency. ARHGDIB, a Rho GTPase regulator implicated in adipogenesis, remains functionally uncharacterized in poultry. Methods: We monitored growth and fat deposition in ducks from 30 to 70 days, performed transcriptomics on adipose tissue, and established an in vitro duck preadipocyte model to assess ARHGDIB function via siRNA knockdown, Oil Red O staining, and RNA-seq. Results: Fat deposition peaked at 50 days. ARHGDIB expression was lowest in fat and decreased during differentiation. Its knockdown significantly enhanced lipid accumulation, upregulated PPARγ and LPL, and altered the expression of 1681 genes enriched in oxidative phosphorylation, insulin/TLR signaling, and autophagy pathways. Conclusions: ARHGDIB acts as a novel negative regulator of duck subcutaneous adipogenesis by suppressing differentiation and modulating an integrated metabolic-inflammatory network, offering a potential target for precision breeding. Full article

Fat deposition plays a crucial role in regulating the production performance and meat quality of broilers. Although the heterogeneity of mammalian adipocytes has been extensively studied, research on the molecular mechanisms underlying differences in lipid droplet accumulation in avian adipocytes remains limited. This study confirmed a significant positive correlation (R² > 0.81, p < 0.001) between the SSC signal and lipid droplet content via fluorescence staining of lipid droplets, Oil Red O staining, and triglyceride (TG) quantification. Based on this, a label-free sorting strategy using SSC signals was established to sort differentiated chicken preadipocytes, obtaining high lipid droplet (H) and low lipid droplet (L) subpopulations, which were subsequently subjected to transcriptome sequencing and differential gene expression (DEG) analysis, followed by GO and KEGG enrichment analysis. The results indicated no significant differences in the expression of adipogenesis marker genes (PPARG, LPL, CD36, PLIN1, PLIN2) between the high lipid droplet (H) and low lipid droplet (L) groups, suggesting that both groups are at similar stages of differentiation. KEGG analysis revealed that both the H vs. NC and L vs. NC comparisons were enriched in common pathways, including the PPAR signaling pathway, ECM–receptor interaction, focal adhesion, cytokine–receptor interaction, and calcium–Apelin signaling pathway, suggesting that both groups of cells had activated the adipogenesis program. GO analysis showed that, in both H vs. NC and L vs. NC comparisons, differentially expressed genes (DEGs) were enriched in biological processes (BPs) related to cell adhesion, nucleosome assembly, chromatin remodeling, and receptor activity, as well as cellular components (CCs) such as the extracellular matrix, cytoskeleton, and nucleosome organization, indicating extensive gene reprogramming and activation of signaling transduction during differentiation. In the H vs. L comparison, enriched pathways included ABC transporters, ECM–receptor interaction, focal adhesion, gap junctions, microtubule-related processes, and neuroactive ligand–receptor interactions, involving lipid transmembrane transport, cytoskeleton stabilization, and signal transduction regulation, suggesting that high lipid droplet cells are more mature in lipid droplet transport, storage, and homeostasis maintenance. GO enrichment results further supported this conclusion, as H vs. L specifically enriched processes related to microtubule-related processes, cell cycle, and redox reactions (BPs), as well as chromosome organization, cytoskeleton, and motor activity (CC/MF), indicating that high lipid droplet cells maintain lipid droplet fusion and metabolic homeostasis via enhanced microtubule transport and antioxidant regulation. Differential gene analysis revealed that the L group upregulated genes associated with fatty acid synthesis and elongation (ACACA, FASN, SCD, FADS2, ELOVL1), cholesterol and isoprenoid biosynthesis (HMGCR, SQLE, MSMO1, DHCR7, DHCR24, FDPS, LSS), and fatty acid oxidation (PPARA, PPARD, ACAD11, SIRT5), reflecting a metabolic characteristic of concurrent lipid synthesis and mobilization; the H group, conversely, upregulated genes associated with lipid droplet formation and storage (G0S2, MOGAT1, GPAT4, PLIN4, AUP1), lipid transport (ABCA1, ABCA2, ABCG1, OSBPL3, VLDLR), and antioxidant defense (GPX3, GPX4, HMOX1), exhibiting a storage and homeostasis-oriented metabolic state. In the NC, L, and H groups, the expression of five genes—GEM, SPP1, ABCA1, PDLIM3, and ITGA8—showed a gradual increase, suggesting that these genes were associated with preadipocyte differentiation and lipid droplet deposition. In summary, although the high and low lipid droplet subpopulations of chicken preadipocytes exhibit similar differentiation states, they form distinct metabolic orientations. The L group is characterized by active lipid synthesis, fatty acid oxidation, and membrane lipid remodeling, while the H group predominantly features lipid droplet storage, lipid transport, and antioxidant homeostasis. This study highlights the molecular mechanisms underlying the metabolic heterogeneity of avian adipocytes and provides a theoretical basis for poultry fat deposition regulation and genetic improvement. Full article